News, reviews and podcasts from annual scientific meetings and symposiums around the world.
Testing solid tumours for genetic changes that can be targeted by drugs has revolutionised the…
An antibody fused to a targeted drug has produced impressive results in a Phase I…
Increasing neoadjuvant pembrolizumab from one to two cycles prior to surgery improved pathological response rates…
Taking medications to protect the heart from damage associated with adjuvant breast cancer therapy (medications…
As breast cancer becomes a largely curable disease, with more than 70% of women surviving…
Adding nivolumab to chemotherapy as neoadjuvant treatment for patients with resectable non-small cell lung cancer…
Treatment with unselected autologous tumour infiltrating lymphocytes (TILs) showed early clinical efficacy among patients with…
Mirati Therapeutics, Inc. announced initial preclinical results evaluating its investigational synthetic lethal PRMT5 inhibitor in…
Clinical trial results of RET kinase inhibitor selpercatinib show that the targeted therapy was effective…
Racial differences in genetic mutations were observed among early-onset colorectal cancers (CRC), according to data…